Wedmont Private Capital Purchases Shares of 906 Waters Co. (NYSE:WAT)

Wedmont Private Capital acquired a new position in Waters Co. (NYSE:WATGet Rating) during the second quarter, HoldingsChannel.com reports. The fund acquired 906 shares of the medical instruments supplier’s stock, valued at approximately $300,000.

A number of other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. lifted its position in shares of Waters by 0.5% in the first quarter. Vanguard Group Inc. now owns 6,689,208 shares of the medical instruments supplier’s stock worth $2,076,263,000 after purchasing an additional 30,274 shares in the last quarter. BlackRock Inc. lifted its position in shares of Waters by 0.6% in the first quarter. BlackRock Inc. now owns 6,108,293 shares of the medical instruments supplier’s stock worth $1,895,953,000 after purchasing an additional 38,739 shares in the last quarter. State Street Corp lifted its position in shares of Waters by 2.6% in the fourth quarter. State Street Corp now owns 2,781,227 shares of the medical instruments supplier’s stock worth $1,036,285,000 after purchasing an additional 70,524 shares in the last quarter. Wellington Management Group LLP lifted its position in shares of Waters by 79.6% in the first quarter. Wellington Management Group LLP now owns 1,504,592 shares of the medical instruments supplier’s stock worth $467,011,000 after purchasing an additional 666,851 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Waters by 1.9% in the fourth quarter. Geode Capital Management LLC now owns 1,183,053 shares of the medical instruments supplier’s stock worth $439,993,000 after purchasing an additional 21,757 shares in the last quarter. Institutional investors own 88.80% of the company’s stock.

Waters Stock Up 2.3 %

Shares of NYSE WAT opened at $290.46 on Tuesday. The company has a current ratio of 2.10, a quick ratio of 1.55 and a debt-to-equity ratio of 3.66. Waters Co. has a 12 month low of $280.75 and a 12 month high of $405.06. The firm has a market capitalization of $17.39 billion, a PE ratio of 25.35, a price-to-earnings-growth ratio of 3.08 and a beta of 0.87. The firm has a fifty day simple moving average of $323.90 and a two-hundred day simple moving average of $321.75.

Waters (NYSE:WATGet Rating) last issued its quarterly earnings data on Tuesday, August 2nd. The medical instruments supplier reported $2.75 EPS for the quarter, topping the consensus estimate of $2.63 by $0.12. The business had revenue of $714.30 million during the quarter, compared to analyst estimates of $706.77 million. Waters had a net margin of 24.21% and a return on equity of 203.31%. The company’s revenue for the quarter was up 4.8% on a year-over-year basis. During the same period in the prior year, the business earned $2.60 EPS. Equities analysts expect that Waters Co. will post 12 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on WAT. Robert W. Baird boosted their target price on shares of Waters from $340.00 to $348.00 in a report on Wednesday, August 3rd. Cowen increased their price objective on shares of Waters to $378.00 in a research report on Tuesday, August 9th. Barclays cut their target price on shares of Waters from $375.00 to $345.00 and set an “overweight” rating on the stock in a research report on Monday, September 12th. UBS Group raised their price target on shares of Waters from $349.00 to $375.00 and gave the company a “neutral” rating in a research note on Thursday, August 4th. Finally, Credit Suisse Group began coverage on shares of Waters in a research note on Wednesday, August 24th. They set a “neutral” rating and a $345.00 target price for the company. Five research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, Waters presently has a consensus rating of “Hold” and a consensus target price of $348.25.

Waters Company Profile

(Get Rating)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Articles

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATGet Rating).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.